ERoad earnings reflect straighter steering, TradeWindow slashes staff
After rocky ride, ERoad eyes up potential $10b US market.
AdvertisementAdvertise with NZME.
Latest fromNZX Limited
Gentrack back in black after surviving UK energy sector slump
Renewable energy subsidies abroad had tipped over several of software firm’s customers.
Market close: NZ stocks drift as company results fail to inspire
It was another topsy-turvy day for the NZ sharemarket.
NZME reveals three-year strategy; bullish about future despite tough market
Media Insider: Digital subscriptions now fund the NZ Herald newsroom.
Reasons to be upbeat about stocks
OPINION: As inflation cools down, what are the signs of a likely boost to the NZX?
Market close: Retirement village stocks weaker as sharemarket slips
The latest reporting season was met with light trading.
Market close: Energy stocks drag NZ shares down
A softer New Zealand sharemarket closed the week with a half per cent fall.
Mainfreight has post-pandemic freight frenzy hangover
The company's sinking lid means it has 500 fewer employees since March.
Sky terminates takeover talks, offers bullish forecast
Board sees "clear path" to doubled dividend by FY2026.
Banking stocks drive NZ sharemarket lower
New Zealand stocks lose some of Monday's gains, driven by weaker banking stocks.
Big agenda and some sticky issues ahead for Fonterra's annual meeting
There will be plenty for shareholders to chew over.
Supie collapse: Five reasons start-ups suddenly find it harder to get funding
A venture capital explainer. Plus: What National will and won’t do for start-ups and VCs.
Market close: High interest rates hurt NZ market
The Israel-Hamas war has created volatility in gold and oil prices.
RBNZ: Kiwi mortgage holders particularly exposed to high interest rates
NZ households highly indebted by international standards.
Mark Lister: The sharemarket is nothing like a casino
OPINION: For genuine investors, the casino comparison couldn’t be further from the truth.
Revealed: The Super Fund's biggest tech stock bets
The tech giants to whom our retirement fortunes are tied.
NZ stocks caught in pincer movement as downtrend continues
New Zealand stocks remained boxed in by high interest rates and modest earnings growth.
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
Market close: Geopolitics, high yields drive NZ stocks lower
The S&P/NZX50 index was at 11,135.58, down 85.90 points or 0.77 per cent.
Market close: NZ market flattens as investors mull over data
The S&P/NZX 50 Index edged up 0.06 per cent.
Market close: Fletcher Building shares plunge, dragging NZ market lower
The market didn't experience the jump that investors thought after the election result.
Genesis Energy board, CEO quizzed on soggy share price
Relative underperformance of share price put down to usage of fossil fuels.
Pipe nightmare: Fletcher Building shares expected to fall
The company's pipe business has turned into a nightmare.
Market close: NZ stocks end flat as investors await Fletcher, election result
Most of the talk in the market was around Fletcher Building.
Mainfreight weighs up risk and opportunities in first climate risk report
The transport company was now considering 'applicable emission targets for the group'.
Market close: NZ market edges up while Fletcher Building goes into trading halt
The S&P/NZX 50 Index rose 13.1 points, or 0.12 per cent.
Market close: NZ market enjoys positive bounce
International funds coming in helped propel the local market.
Market close: NZ market in the red as election countdown begins
It was a slow day for the market with light volumes traded.
Market close: Pacific Edge falls as NZ market sinks into the red
No reason for optimism as we enter 'bear killer' month.
Stock Takes: Synlait’s big reveal, Fisher and Paykel's investor day
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
Say cheese: What drove Fonterra’s record $1.6b profit
Cheese and protein portfolios propel surge in Fonterra profit.
NZ King Salmon sizzles in latest result
Fewer fish dying prematurely, company says turnaround gaining steam.
NZ market edges up while Synlait Milk shares drop 10 per cent
A2 Milk wants to cancel Synlait’s exclusive milk formula production and supply deal.
Stock Takes: NZ market into negative territory, Peter Beck explains why he sold $34m worth of Rocket Lab shares
The NZX50 dropped 12 per cent last year and is on track for another down year.